Candid Health vs Collectly (2026)
Both improve what a practice actually collects and they work opposite ends of the ledger. Candid automates the payer side for medical groups and digital health companies, running claim submission through payment as one continuous path and putting a single outcome metric at the centre of its pitch. Collectly works the patient responsibility portion, which has grown from a minor line into a large share of provider revenue as deductibles rose, and which fails for behavioural reasons rather than technical ones. Most growing practices need both eventually. The sequencing depends on where your receivable is ageing: if denials and payer lag dominate, Candid first; if the balance sitting uncollected is increasingly owed by patients, no amount of claims automation reaches it.
- It automates the revenue cycle for medical groups and digital health companies around a single headline metric, so the vendor is measured on the outcome rather than on activity.
- The buyer is a group practice or a digital health company rather than a hospital, and the product is scoped to that operating model rather than adapted down from an enterprise platform.
- Claim submission through payment is one continuous automated path rather than a set of assisted steps.
- It works the patient responsibility portion specifically, which the company notes has grown into a much larger share of provider revenue than it was.
- Patient billing is a communication and behaviour problem as much as a financial one, and a product built for that is different from a claims engine pointed at consumers.
- For an organisation whose collectible balance sits with patients rather than payers, this is where the money actually is.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Candid Health and Collectly are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Candid Health | Collectly |
|---|---|---|
| Primary category | RCM & Prior Auth AI | RCM & Prior Auth AI |
| Headquarters | San Francisco, California, United States | Santa Monica, California |
| Website | candidhealth.com | collectly.co |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Candid Health its top capability grade on Autonomy and Oversight Model and EHR and Interoperability Depth. Set against Collectly, Candid Health grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and AI Safety and PHI Stewardship. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Collectly its top capability grade on Security Certifications and Trust Center, EHR and Interoperability Depth and Setting and Specialty Coverage. Set against Candid Health, Collectly grades higher on Clinical and Operational Evidence, Security Certifications and Trust Center and Setting and Specialty Coverage. Its thinnest published disclosure sits on AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Candid Health or Collectly?
On the axes where the AI Health Index separates them, Candid Health grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and AI Safety and PHI Stewardship, and Collectly grades higher on Clinical and Operational Evidence, Security Certifications and Trust Center and Setting and Specialty Coverage. Candid Health leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Candid Health and Collectly differ most?
The widest separation the AI Health Index records between Candid Health and Collectly is on AI Liability and Recourse, where Candid Health grades B and Collectly grades D. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Candid Health and Collectly grade the same?
The AI Health Index grades Candid Health and Collectly the same on several axes, including AI Centrality, Model Supply Chain Disclosure and HIPAA and BAA Posture. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Candid Health and Collectly not disclosed?
At the last review, at least one of Candid Health and Collectly published thin or absent detail on AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
These address different halves of the same ledger and a growing practice will usually need both, so the comparison is about sequencing rather than selection: payer claims automation first if denials and lag dominate, patient collections first if the receivable is increasingly consumer owed.
Neither vendor publishes pricing in a comparable form, and collections products in particular are frequently priced as a share of recovered cash, which is a materially different commitment from a per provider fee. Neither publishes a subgroup analysis, which matters in patient billing because outreach that performs worse for some populations produces worse collection outcomes for exactly the patients least able to absorb the balance.